The natural breakthrough: phytochemicals as potent therapeutic agents against spinocerebellar ataxia type 3
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
The natural breakthrough: phytochemicals as potent therapeutic agents against spinocerebellar ataxia type 3 ; volume:14 ; number:1 ; day:17 ; month:1 ; year:2024 ; pages:1-13 ; date:12.2024
Scientific reports ; 14, Heft 1 (17.1.2024), 1-13, 12.2024
- Urheber
-
Naveed, Muhammad
Ali, Nouman
Aziz, Tariq
Hanif, Nimra
Fatima, Mahnoor
Ali, Imran
Alharbi, Metab
Alasmari, Abdullah F.
Albekairi, Thamer H.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-51954-3
- URN
-
urn:nbn:de:101:1-2024032915472041447134
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Naveed, Muhammad
- Ali, Nouman
- Aziz, Tariq
- Hanif, Nimra
- Fatima, Mahnoor
- Ali, Imran
- Alharbi, Metab
- Alasmari, Abdullah F.
- Albekairi, Thamer H.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Spinocerebellar ataxia: an update
Spinocerebellar Ataxia Type 2
Spinocerebellar ataxia type 31 (SCA31)
Dysregulated pathways in spinocerebellar ataxia type 2 and ataxia telangectasia
Autonomic function testing in spinocerebellar ataxia type 2
Abnormal eye movements in spinocerebellar ataxia type 3
Spinocerebellar ataxia type 3 presenting simultaneously with motor neuron disease and cerebellar ataxia
Optimized testing strategy for the diagnosis of GAA-FGF14 ataxia/spinocerebellar ataxia 27B
Neural correlates of ataxia severity in spinocerebellar ataxia type 3/Machado-Joseph disease
Frequency of Spinocerebellar Ataxia type 1, 2, 3,6 and 7 and clinical profile of Spinocerebellar Ataxia type 3 in Malaysia
Epilepsy in spinocerebellar ataxia type 8: a case report
Neurochemical Differences in Spinocerebellar Ataxia Type 14 and 1
Spinocerebellar ataxia: an update
Spinocerebellar Ataxia Type 2
Spinocerebellar ataxia type 31 (SCA31)
Dysregulated pathways in spinocerebellar ataxia type 2 and ataxia telangectasia
Autonomic function testing in spinocerebellar ataxia type 2
Abnormal eye movements in spinocerebellar ataxia type 3
Spinocerebellar ataxia type 3 presenting simultaneously with motor neuron disease and cerebellar ataxia
Optimized testing strategy for the diagnosis of GAA-FGF14 ataxia/spinocerebellar ataxia 27B
Neural correlates of ataxia severity in spinocerebellar ataxia type 3/Machado-Joseph disease
Frequency of Spinocerebellar Ataxia type 1, 2, 3,6 and 7 and clinical profile of Spinocerebellar Ataxia type 3 in Malaysia
Epilepsy in spinocerebellar ataxia type 8: a case report
Neurochemical Differences in Spinocerebellar Ataxia Type 14 and 1
Spinocerebellar ataxia: an update
Spinocerebellar Ataxia Type 2
Spinocerebellar ataxia type 31 (SCA31)
Dysregulated pathways in spinocerebellar ataxia type 2 and ataxia telangectasia
Autonomic function testing in spinocerebellar ataxia type 2
Abnormal eye movements in spinocerebellar ataxia type 3
Spinocerebellar ataxia type 3 presenting simultaneously with motor neuron disease and cerebellar ataxia
Optimized testing strategy for the diagnosis of GAA-FGF14 ataxia/spinocerebellar ataxia 27B
Neural correlates of ataxia severity in spinocerebellar ataxia type 3/Machado-Joseph disease
Frequency of Spinocerebellar Ataxia type 1, 2, 3,6 and 7 and clinical profile of Spinocerebellar Ataxia type 3 in Malaysia
Epilepsy in spinocerebellar ataxia type 8: a case report